Phibro Animal Health Corporation
PAHC
$38.25
-$0.33-0.86%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 3.44% | 2.58% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.44% | 2.58% | |||
| Cost of Revenue | 5.03% | 7.26% | |||
| Gross Profit | 0.18% | -5.86% | |||
| SG&A Expenses | 4.87% | -1.28% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.71% | 5.16% | |||
| Operating Income | -12.35% | -12.40% | |||
| Income Before Tax | 0.09% | -11.29% | |||
| Income Tax Expenses | 28.25% | -7.55% | |||
| Earnings from Continuing Operations | -9.63% | -12.51% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -9.63% | -12.51% | |||
| EBIT | -12.35% | -12.40% | |||
| EBITDA | -10.85% | -10.70% | |||
| EPS Basic | -9.74% | -12.55% | |||
| Normalized Basic EPS | -26.40% | -12.83% | |||
| EPS Diluted | -10.19% | -11.94% | |||
| Normalized Diluted EPS | -26.24% | -12.96% | |||
| Average Basic Shares Outstanding | 0.12% | 0.04% | |||
| Average Diluted Shares Outstanding | -0.09% | 0.20% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 0.11% | 0.14% | |||